Looking for an exciting opportunity to play a key role in business integration across Europe and beyond?
GenePlanet, EU based biotech company, a global leader in the field of preventive genetic tests; specializing in NIPT, cancer screening, and lifestyle DNA tests, is looking for a Business Integration Associate. With a presence in 45+ markets worldwide and a passionate team of over 200 employees, GenePlanet collaborates with over 5.000 medical centers, doctors, and insurance companies to provide top-quality tests based on the latest scientific discoveries. Our tests are designed to empower individuals to take control of their and their baby's health, as well as assist doctors with therapeutic procedures.
In this role, you will be responsible for supporting the management and integration of companies we acquire and merge into our organization. The ideal candidate will possess a strong commercial acumen, a solid understanding of financial data, and a business-oriented mindset.
Key Responsibilities:
Requirements:
If you are a business-oriented professional with a passion for helping companies grow and integrate, we would love to hear from you!

GenePlanet is the leading European provider of preventive genetic tests, specialising in NIPT, cancer screening, and lifestyle DNA tests.
With over 15 years of experience in the market, GenePlanet collaborates with over 1000 medical centres, doctors, and insurance companies to provide top-quality tests based on the latest scientific discoveries.
The company’s tests are designed to empower individuals to take control of their and their baby’s health, as well as assist doctors with therapeutic procedures.
GenePlanet adheres to the highest standards of quality and is constantly striving for new discoveries through its research and development efforts.
With a presence in more than 35 countries worldwide and over 100,000 satisfied customers, GenePlanet has been recognised as one of the 1000 fastest-growing companies in the EU by the Financial Times and one of the Top 35 EU Unicorns by the European Commission.